The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
3D printed medicines: A new branch of digital healthcare
Open accessAbstract
ABSTRACT Three‐dimensional printing (3DP) is a highly disruptive technology with the potential to change the way pharmaceuticals are designed, prescribed and produced. Owing to its low cost, diversity, portability and simplicity, fused deposition modeling (FDM) is well suited to a multitude of pharmaceutical applications in digital health. Favourably, through the combination of digital and genomic technologies, FDM enables the remote fabrication of drug delivery systems from 3D models having unique shapes, sizes and dosages, enabling greater control over the release characteristics and hence bioavailability of medications. In turn, this system could accelerate the digital healthcare revolution, enabling medicines to be tailored to the individual needs of each patient on demand. To date, a variety of FDM 3D printed medical products (e.g. implants) have been commercialised for clinical use. However, within pharmaceuticals, certain regulatory hurdles still remain. This article reviews the current state‐of‐the‐art in FDM technology for medical and pharmaceutical research, including its use for personalised treatments and interconnection within digital health networks. The outstanding challenges are also discussed, with a focus on the future developments that are required to facilitate its integration within pharmacies and hospitals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Sydney Gladman, A., Matsumoto, E. A., Nuzzo, R. G., Mahadevan, L., & Lewis, J. A. (2016) · Nature Materials · doi:10.1038/nmat4544 · Cited by 3,027
3-D printing: The new industrial revolution
Berman, B. (2012) · Business Horizons · doi:10.1016/j.bushor.2011.11.003 · Cited by 2,481
Estimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585
4D Printing: Multi‐Material Shape Change
Tibbits, S. (2014) · Architectural Design · doi:10.1002/ad.1710 · Cited by 1,188
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
Norman, J., Madurawe, R. D., Moore, C. M. V., Khan, M. A., & Khairuzzaman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.001 · Cited by 810
Effect of geometry on drug release from 3D printed tablets
Goyanes, A., Robles Martinez, P., Buanz, A., Basit, A. W., & Gaisford, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.069 · Cited by 667
Self-citation3D printing in pharmaceutics: A new tool for designing customized drug delivery systems
Goole, J., & Amighi, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.071 · Cited by 660
Stereolithographic (SLA) 3D printing of oral modified-release dosage forms
Wang, J., Goyanes, A., Gaisford, S., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.016 · Cited by 612
Self-citationFused-filament 3D printing (3DP) for fabrication of tablets
Goyanes, A., Buanz, A. B. M., Basit, A. W., & Gaisford, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.044 · Cited by 587
Self-citation
Cited by
3D Printing as a Promising Tool in Personalized Medicine
Vaz, V. M., & Kumar, L. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-020-01905-8 · Cited by 409
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Shaping the future: recent advances of 3D printing in drug delivery and healthcare
Trenfield, S. J., Awad, A., Madla, C. M., Hatton, G. B., Firth, J., Goyanes, A., Gaisford, S., & Basit, A. W. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1660318 · Cited by 299
Self-citationGoyanes, A., Madla, C. M., Umerji, A., Duran Piñeiro, G., Giraldez Montero, J. M., Lamas Diaz, M. J., Gonzalez Barcia, M., Taherali, F., Sánchez-Pintos, P., Couce, M.-L., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118497 · Cited by 292
Self-citationPrinting T3 and T4 oral drug combinations as a novel strategy for hypothyroidism
Alomari, M., Vuddanda, P. R., Trenfield, S. J., Dodoo, C. C., Velaga, S., Basit, A. W., & Gaisford, S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.062 · Cited by 77
Self-citation
Metadata
- Authors
- Awad, A., Trenfield, S. J., Gaisford, S., & Basit, A. W.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 548
- Issue
- 1
- Pages
- 586-596
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2832872449
- Cited by
- 265
- References
- 110
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3D printed medicines: A new branch of digital healthcare. https://app.cochat.ai/papers/10.1016/j.ijpharm.2018.07.024
- The paper
- Awad, A., Trenfield, S. J., Gaisford, S., & Basit, A. W. (2018). 3D printed medicines: A new branch of digital healthcare. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.07.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
